Post-therapy change in prostate-specific antigen levels as a clinical trial endpoint in hormone-refractory prostatic cancer: a trial with 10-ethyl-deaza-aminopterin (Q41025718)

From Wikidata
Jump to navigation Jump to search
scientific article published on August 1994
edit
Language Label Description Also known as
English
Post-therapy change in prostate-specific antigen levels as a clinical trial endpoint in hormone-refractory prostatic cancer: a trial with 10-ethyl-deaza-aminopterin
scientific article published on August 1994

    Statements

    Post-therapy change in prostate-specific antigen levels as a clinical trial endpoint in hormone-refractory prostatic cancer: a trial with 10-ethyl-deaza-aminopterin (English)
    P K Schultz
    W K Kelly
    C Begg
    C Liebertz
    L Cohen
    H I Scher
    1 August 1994
    237-242

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit